JCDR - Register at Journal of Clinical and Diagnostic Research
Journal of Clinical and Diagnostic Research, ISSN - 0973 - 709X
Microbiology Section DOI : 10.7860/JCDR/2015/11014.5398
Year : 2015 | Month : Jan | Volume : 9 | Issue : 1 Full Version Page : DC08 - DC10

Biofilm Producing Multidrug Resistant Acinetobacter baumannii: An Emerging Challenge

Gitanjali Kailas Badave1, Dhananjay Kulkarni2

1 Assistant Professor, Department of Microbiology, Konaseema Institute of Medical Science & Research Foundation, Amalapuram, Andhra Pradesh, India.
2 Assistant Professor, Department of Pharmacology, Konaseema Institute of Medical Science & Research Foundation, Amalapuram, Andhra Pradesh, India.


NAME, ADDRESS, E-MAIL ID OF THE CORRESPONDING AUTHOR: Dr. Gitanjali Kailas Badave, Assistant Professor, Department of Microbiology, Konaseema Institute of Medical Science & Research Foundation, Amalapuram (E.G)-533201, Andhra Pradesh, India. E-mail : badve.gitanjali@gmail.com
Abstract

Aim: To study the quantitative method for biofilm formation and examine the correlation between biofilm formation and antibiotic resistance among the clinical isolates of Acinetobacter baumannii.

Materials and Methods: A total of 72 A. baumannii isolates from different clinical specimens were processed and confirmed by conventional microbiological methods. Antimicrobial susceptibility testing was performed by Kirby Bauer disc diffusion method using six antibiotics. Biofilm formation was studied by microtitre plate assay.

Results: Forty five (62.5%) of 72 isolates produced biofilm. Resistance to ampicillin-sulbactam was least. 36.1% isolates were resistant to imipenem, 66.6% to ceftazidime, 72.2% to ciprofloxacin, 80.5% to amikacin and 84.7% to piperacillin. Biofilm formers showed greater resistance to ampicillin- sulbactam, amikacin, ciprofloxacin and ceftazidime as compared to imipenem and piperacillin. In all 65 (90.3%) isolates showed multiple drug resistance. Correlation between multidrug resistance and biofilm formation was analysed statistically and p-value was found to be significant (p-value =0.0004; p-value < 0.05 is significant by Chi – Square Test).

Conclusion: The study concludes that there a positive correlation between biofilm formation and multiple drug resistance in A. baumannii.

Keywords

Introduction

Acinetobacter baumannii, a gram negative non fermenter organism, has emerged as one of the most troublesome pathogens for health care institutions globally. This organism commonly targets the most vulnerable hospitalized patients causing pneumonia particularly in patients on mechanical ventilation, urinary tract infection, bloodstream infections, skin infections etc. It accounts for about 10% of all nosocomial infections [1,2]. Its clinical significance over last 15 years has been propelled by its remarkable ability to acquire resistant determinants, making it one of the organisms threatening the current antibiotic era. Acinetobacter strains resistant to all known antibiotics have been reported and acting in synergy with this emerging resistance profile is the ability of Acinetobacter to survive for long periods throughout the hospital environment [2,3].

Acinetobacter frequently causes infections associated with medical devices, e.g. vascular catheters, cerebrospinal fluid shunts or Foleys catheter. Biofilm formation is a well-known pathogenic mechanism in such infections. The potential of Acinetobacter to form biofilm may explain its exceptional antibiotic resistance and survival in the hospital environment [3,4].

A positive correlation between the biofilm formation and drug resistance in the form of extended spectrum β - lactamase (ESBL) bla PER-1 gene among the A. baumannii isolates has already been reported [5]. Therefore, the present study was undertaken to study biofilm formation and correlation between biofilm formation and the multiple drug resistance in A. baumannii.

Materials and Methods

Bacterial isolates and antimicrobial susceptibility testing

The present study was conducted in Department of Microbiology, Konaseema Institute of Medical Sciences (KIMS), Amalapuram, for seven months duration period from January 2014 to July 2014. A total of 72 isolates of A. baumannii were obtained for study from various clinical specimens like endotracheal aspirates, cerebrospinal fluid, pus, wound swabs, urine, blood culture specimens, body fluids etc. from the patients admitted in hospital. All the isolates were processed and confirmed by conventional microbiological methods using phenotypic test [68]. All 72 isolates were tested for antimicrobial susceptibility with amikacin (30 μg), ampicillin-sulbactam (10/10 μg), ceftazidime (30 μg), ciprofloxacin (5 μg), imipenem (10 μg), piperacillin (100 μg) by Kirby Bauer disc diffusion method. Interpretation of antimicrobial susceptibility testing by disc diffusion test was done as per Clinical Laboratory and Standard Institute (CLSI) Guidelines [9,10].

Biofilm formation [11,12]

This was determined by microtitre plate method. Each isolate was grown overnight in trypticase soy broth (TSB) with 0.25% glucose at 37oC. The overnight growth was diluted in a ratio of 1:40 in TSB-0.25 % glucose. Two hundred microlitre of cell suspension was inoculated in sterile 96 well polystyrene microtitre plates. After 24 h of incubation, the wells were gently washed three times with 200 microlitre of phosphate buffered saline (PBS) then dried in an inverted position and stained with 1% crystal violet for 15 min. The wells were rinsed again in 200 microlitre of ethanol-acetone (80:20 v/v) to solubilise crystal violet. The optical density at 620 nm (OD 620) was determined using microplate reader. Each assay was performed in triplicate and the average optical density was considered.

The following values were assigned for biofilm determination:

Non-biofilm producer: OD620 < 0.275

Weak biofilm producer: 0.275 ≤ OD 620<0.55

Medium biofilm producer: 0.55≤ OD620<0.825

Strong biofilm producer: 0.825 ≤OD620

The number 0.275 was chosen for guideline because it was three standard deviations above the mean OD (0.303) of a clean microtitre plate stained by the above method.

Results

In the present study, a total of 45 (62.5%) isolates produced biofilm. The results of quantitative assay for biofilm formation are shown in [Table/Fig-1]. Drug resistance pattern shows isolates are least resistant to ampicillin-sulbactam (25%) and highest resistant for piperacillin (84.7%). Details of resistance pattern for other antibiotics are mentioned in [Table/Fig-2].

Biofilm formation in A. baumannii

Biofilm formationNo. of isolates (%)
1Formers45 (62.5)
 - Weak03 (6.67%)
 - Medium05 (11.11%)
 - Strong37 (82.22%)
2Non formers27 (37.5)

Resistance pattern to antimicrobials in A.baumannii

Name of antimicrobialNo of resistant Isolates (%)n=72Biofilm positive resistant isolates (%)Biofilm positive resistant isolates (%)
1Ampicillin Sulbactam18 (25)10 (55.5)8 (44.5)
2.Piperacillin61 (84.7)26 (42.6)35 (57.4)
3.Amikacin58 (80.5)31 (53.4)27 (46.6)
4.Ciprofloxacin52 (72.2)26 (50)26 (50)
5.Ceftazidime48 (66.6)25 (52.08)23 (47.92)
6.Imipenem26 (36.1)10 (38.4)16 (61.6)

Comparison of resistance pattern of biofilm forming A. baumannii isolates with non biofilm formers is shown in [Table/Fig-3]. Biofilm formers showed greater resistance for ampicillin- sulbactam, amikacin, ciprofloxacin and ceftazidime as compared to imipenem and piperacillin. In all 65 (90.3%) isolates showed multiple drug resistance [Table/Fig-4]. Further correlation between multidrug resistance and biofilm formation was analysed statistically by Chi–Square Test and p-value (0.0004) was found to be significant [Table/Fig-5].

Distribution of A.baumannii resistant isolates: Biofilm vs. non biofilm formers

Frequency of multiple drug resistance in A. baumannii

No .of resistant antimicrobial agentsNo. of isolates (%) n=72Biofilm positive resistant isolates
01 (1.4)1
16 (8.3)4
2*8 (11.1)4
3*13 (18.1)9
4*20 (27.8)16
5*19 (26.4)9
6*5 (6.9)2
Total7245

* No. of MDR (resistant to two or more antimicrobials) isolates is 65 (90.3%)


Correlation between multiple drug resistance and biofilm formation in A.baumannii (statistical analysis)

Biofilm formationMultiple drug resistance
PositiveNegativeTotal
Positive40545
Negative25227
Total65772

(p-value = 0.0004; p-value < 0.05 is significant by Chi – Square Test)


Discussion

Of the “newer” pathogens now recognized, Acinetobacter baumannii plays a significant role in colonization and infection of patients admitted to hospitals. They have been implicated in a variety of nosocomial infections, including bacteremia, urinary tract infections and secondary meningitis but their predominant role is as agents of nosocomial pneumonia, particularly ventilator associated pneumonia in patients confined to intensive care units (ICU’s). Such infections are often extremely difficult to treat for the clinician because of widespread resistance of the virulent organism to a large number of antibiotics [13].

A.baumannii clinical isolates have the ability to survive long stretches of time under highly desiccated conditions on abiotic surfaces [14,15]. Rodriguez et al., showed that the ability to form biofilms on abiotic surfaces is a common trait among A. baumannii strains, particularly isolated from catheter-related urinary tract infection or bloodstream infection as well as a case of shunt-related meningitis [4]. Biofilm is a group of microorganisms in which bacterial cells are adherent to each other and embedded within a self-produced matrix of extracellular polymeric substance or exopolysaccharide (EPS) [16].

Generally, two properties are often associated with biofilm producing bacteria, namely, the increased synthesis of exopolysaccharide and the development of antibiotic resistance [16]. Increased production of EPS in A. baumannii is likely to create a protective environment causing difficulty in antibiotic penetration leading to development of resistance. Also, there are differences in the cellular physiology of cells within the biofilm that results in increased drug resistance [17]. The ability of bacterial cells to transfer genes horizontally is enhanced within biofilm communities, thereby facilitating the spread of antibiotic resistance [18].

We selected to study biofilm formation by clinical isolates of A. baumannii and its correlation with multiple drug resistance in order to understand the ability of A.baumannii to persist in the hospital environment to cause outbreaks. In the present study, 62.5% isolates produced biofilm as assessed by microtitre plate method. Similar occurrence of 63% and 62% biofilm formers have also been reported by Rodriguez et al., [4] and Rao et al., [19] respectively. A recent study, although done by tube method reported positivity of 50% for biofilm formation in A.baumannii isolates [20].

In the present study, biofilm formers showed greater resistance to ampicillin- sulbactam, amikacin, ciprofloxacin and ceftazidime as compared to imipenem and piperacillin. Nahar et al., has reported even 100% resistance to amoxicillin, ceftriaxone, ceftazidime, cefuroxime, and aztreonam in biofilm forming Acinetobacter species. Also in the same study, resistance to gentamicin, amikacin, netilmicin, ciprofloxacin and imipenem was higher among biofilm forming Acinetobacter isolates particularly from ICU patients [21]. In the present study, less resistance to imipenem and piperacillin in biofilm formers could be due to ability of both the antibiotics to penetrate the biofilm, inhibiting the bacterial growth. This finding is supported by a research on permeation of antibiotics through biofilms which demonstrates that piperacillin and imipenem have relatively high permeation with penetration through biofilm as compared to aminoglycosides or fluroquinolones [22].

Considering multiple drug resistance as resistance to two or more antimicrobial agents [23], 90.3% isolates showed multiple drug resistance in the present study. Statistical analysis proved a significant correlation between multiple drug resistance and biofilm formation, which is in accordance to the findings reported by various studies [1921]. Conversely, a reciprocal study to investigate various virulence factors in known MDR (ciprofloxacin-imipenem-trimethoprim/sulfamethoxazole-resistant) A.baumannii isolates, reported that 24.6% MDR isolates produced biofilm thereby suggesting a synergistic relationship of biofilm formation with multiple drug resistance [24].

Thus, A. baumannii strains capable of forming biofilm might be selected under antibiotic pressure, or conversely, A. baumannii might acquire resistance to multiple drugs within biofilm communities. In either event, the high colonizing capacity of A. baumannii, combined with its resistance to multiple drugs, will contribute to the organism’s survival and further dissemination in the hospital setting. Thus, the functions of the biofilm formed by A. baumannii encompass its ability to resist antimicrobial therapies as well as to protect from external stresses such as dehydration and limited nutrient availability [17,18].

Rao et al., reported a significant association between multidrug resistance and biofilm, although the study shows that the presence of blaPER-1 is more critical for cell adhesion than the formation of bacterial biofilms on abiotic surfaces [19]. It was observed that cell adhesiveness and biofilm formation on plastic is higher in strains harboring the blaPER-1 gene than in those that do not harbor this genetic trait. Further, the level of expression of this gene, as determined by reverse transcription-PCR, is positively correlated with the level of biofilm formed on plastic and the adhesiveness of bacteria to human epithelial cells [25].

Conclusion

This study concludes that there is a positive correlation between biofilm formation and multiple drug resistance in A. baumannii. This study needs further molecular support like detection of blaPER -1 gene to provide a quantum leap in our understanding of not only biofilm formation but also its virulence, responsible for multidrug resistance and survival in hospital environment.

* No. of MDR (resistant to two or more antimicrobials) isolates is 65 (90.3%)(p-value = 0.0004; p-value < 0.05 is significant by Chi – Square Test)

References

[1]Karlowsky JA, Draghi DC, Jones ME, Thornsberry C, Friedland IR, Sahm D, Surveillance for antimicrobial susceptibility among clinical isolates of Pseudomonas aeruginosa and Acinetobacter baumannii from hospitalized patients in the United States, 1998–2001 Antimicrob Agents Chemother 2003 47:1681-88.  [Google Scholar]

[2]Guillou Joly ML, Clinical impact and pathogenicity of Acinetobacter Clin Microbiol Infect 2005 11:868-73.  [Google Scholar]

[3]Peleg AY, Seifert H, Paterson DL, Acinetobacter baumannii: emergence of a Successful pathogen Clin Microbiol Rev 2008 21:538-82.  [Google Scholar]

[4]Rodriguez BJ, Marti S, Soto S, Fernandez CF, Cisneros JM, Pachon J, Biofilm formation in Acinetobacter baumannii: associated features and clinical implications Clin Microbiol Infect 2008 14(3):276-78.  [Google Scholar]

[5]Rahbar MR, Rasooli I, Gargari SL, Amani J, Fattahian Y, In silico analysis of antibody triggering biofilm associated protein in Acinetobacter baumannii Journal of Theoretical Biology 2010 266(2):275-90.  [Google Scholar]

[6]Winn WC, Koneman EW, Allen SD, Janda WM, Schreckenberger PC, Woods GL, The Non Fermentative Gram Negative Bacilli In: Koneman’s Color Atlas and Textbook of Diagnostic Microbiology 2006 6th EdPhiladelphiaLippincott Company Williams and Wilkins:353-57.  [Google Scholar]

[7]Gerner Smidt P, Tjernberg I, Ursing J, Reliability of phenotypic tests for identification of Acinetobacter species J Clin Microbiol 1991 29:277-82.  [Google Scholar]

[8]Collee JG, Miles RS, Watt B, Test for identification of bacteria, in Chapter: 7 Mackie & McCartney’s Practical Medical Microbiology 2008 14th edChurchill LivingstoneIndian Reprint:131-49.In: JG Collee, AG Fraser, BP Marmion, A Simmons, Editors  [Google Scholar]

[9]Bauer AW, Kirby WM, Sherris JC, Turuk M, Antimicrobial susceptibility testing by standardized single disc method Am J Clin Pathol 1966 45(4):493-96.  [Google Scholar]

[10]Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility testing; Twenty third Informational Supplement. CLSI document M100-S23.Wayne, PA:Clinical and Laboratory Standards Institute; 2013  [Google Scholar]

[11]Toledo AA, Valle J, Solano C, Arrizubieta MJ, Cucarella C, Lamata M, The enterococcal surface protein, Esp, involved in Enterococcus faecalis biofilm formation Appl Environ Microbiol 2001 6:4538-45.  [Google Scholar]

[12]Christensen GD, Simpson WA, Younger JJ, Baddour LM, Barrett FF, Melton DM, Adherence of coagulase-negative staphylococci to plastic tissue culture plates: a quantitative model for the adherence of staphylococci to medical devices J Clin Microbiol 1985 22(6):996-1006.  [Google Scholar]

[13]Bergone Berezin E, Towner KJ, Acinetobacter spp. as Nosocomial Pathogens: Microbiological, Clinical, and Epidemiological Features Clin Microbiol Rev 1996 9:148-65.  [Google Scholar]

[14]Jawad A, Seifert H, Snelling AM, Heritage J, Hawkey PM, Survival of Acinetobacter baumannii on dry surfaces: comparison of outbreak and sporadic isolates J Clin Microbiol 1998 36:1938-41.  [Google Scholar]

[15]Wendt C, Dietze B, Dietz E, Ruden H, Survival of Acinetobacter baumannii on dry surfaces J Clin Microbiol 1997 35:1394-97.  [Google Scholar]

[16]Costerton JW, Stewart PS, Greenberg EP, Bacterial biofilms: a common cause of persistent infections Science 1999 284:1318-22.  [Google Scholar]

[17]Lewis K, Riddle of biofilm resistance Antimicrob Agents Chemother 2001 45:999-1007.  [Google Scholar]

[18]Donlan RM, Costerton JW, Biofilms: survival mechanisms of clinically relevant microorganisms Clin Microbiol Rev 2002 15:167-93.  [Google Scholar]

[19]Rao RS, Karthika RU, Singh SP, Shashikala P, Kanungo R, Jayachandran S, Correlation between biofilm production and multiple drug resistance in imipenem resistant clinical isolates of Acinetobacter baumannii Indian J Med Microbiol 2008 26:333-37.  [Google Scholar]

[20]Gurung J, Khyriem AB, Banik A, Lyngdoh WV, Choudhury B, Bhattacharyya P, Association of biofilm production with multidrug resistance among clinical isolates of Acinetobacter baumannii and Pseudomonas aeruginosa from intensive care unit Indian J Crit Care Med 2013 17:214-18.  [Google Scholar]

[21]Nahar A, Anwar S, Ruhul M, Association of Biofilm Formation with Antimicrobial Resistance Among the Acinetobacter Species in A Tertiary Care Hospital in Bangladesh J Medicine 2013 14:28-32.  [Google Scholar]

[22]Shigeta M, Tanaka G, Komatsuzawa H, Sugai M, Suginaka H, Usui T, Permeation of antimicrobial agents through Pseudomonas aeruginosa biofilm: a simple method Chemotherapy 1997 43(5):340-45.  [Google Scholar]

[23]Moniri R, Kheltabadi FR, Shajari G, Nazem S, Ghasemi A, Molecular Epidemiology of Aminoglycoside Resistance in Acinetobacter Spp. with Emergence of Multidrug-Resistant Strains Iranian J Publ Health 2010 39(2):63-68.  [Google Scholar]

[24]Erac B, Yilmaz FF, Hosgor LM, Ozturk I, Aydemir S, Investigation of the virulence factors of multidrug-resistant Acinetobacter baumannii isolates Mikrobiyol Bul 2014 48(1):70-81.  [Google Scholar]

[25]Lee HW, Koh YM, Kim J, Capacity of multidrug-resistant clinical isolates of Acinetobacter baumannii to form biofilm and adhere to epithelial cell surfaces Clin Microbiol Infect 2008 14:49-54.  [Google Scholar]